Open AccessIncreased duration of dual pegylated interferon and ribavirin therapy for genotype 1 hepatitis C Post-liver transplantation increases sustained virologic response: A retrospective review
Author(s) -
Malcolm Wells,
L Roth,
Paul Marotta,
Mark Levstik,
Andrew L. Mason,
Vincent G. Bain,
Natasha Chandok,
Bandar Al-Judaıbı
Publication year - 2013
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.118133
Subject(s) - medicine , ribavirin , pegylated interferon , gastroenterology , hepatitis c , hepatitis c virus , transplantation , retrospective cohort study , viral load , liver transplantation , odds ratio , surgery , immunology , virus
In patients with advanced post-transplant hepatitis C virus (HCV) recurrence, antiviral treatment (AVT) with interferon and ribavirin is indicated to prevent graft failure. The aim of this study was to determine and report Canadian data with respect to the safety, efficacy, and spontaneous virologic response (SVR) predictors of AVT among transplanted patients with HCV recurrence.